首页 > 最新文献

Journal "Medicine"最新文献

英文 中文
Comparative analysis of chromosomal aberrations in children with acute leukemia 急性白血病患儿染色体畸变的比较分析
Pub Date : 2020-12-13 DOI: 10.31082/1728-452x-2020-215-216-5-6-7-14
Zhansaya Nessipbayeva, M. Bulegenova, M. Karazhanova, Dina Nurpisova
Leukemia is a hematopoetic tissue tumor with a primary lesion of the bone marrow, where the morphological substrate is the blast cell. Chromosomal and molecular genetic aberrations play a major role in the acute leukemia pathogenesis, determing the morphological, immunological and clinical features of the disease. Our study was aimed to to analyze retrospectively the structure and frequency of chromosomal aberrations in children with initially diagnosed acute leukemia. Material and methods. Medical histories retrospective analysis of children charged to oncohematology department of the «Scientific Center of Pediatrics and Pediatric Surgery» in Almaty for the period 2015 - 2017 was carried out. 310 histories with primary diagnosed acute leukemia were studied. Results and discussion. Among 310 patients different chromosome aberrations were isolated in 158 patients (51%) during cytogenetic and molecular cytogenetic (in situ hybridization) studies of bone marrow blast cells. A normal karyotype was observed in 102 patients (33%). Conclusion. The lymphoblastic variant of acute leukemia was determined in 75.5%, that indicates its leading role in AL structure among the children of different ages. AML was determined in 22.6% of all OL cases. The most frequent chromosomal rearrangement in ALL patients was blast cell chromosome hyperdiploidy (10,6%) and t(12;21)(p13;q22)/ETV6-RUNX1,which was detected in 37 (16%) patients. The most frequent AML abberation was t (8;21) (q22;q22)/RUNX1-RUNX1T1, identified in 15 (21.4%) patients. Keywords: acute leukemia, bone marrow, blast cells, karyotype, chromosomal aberrations, cytogenetic study.
白血病是一种骨髓原发病变的造血组织肿瘤,其形态基质为母细胞。染色体和分子遗传畸变在急性白血病发病中起重要作用,决定了疾病的形态学、免疫学和临床特征。本研究旨在回顾性分析初诊急性白血病患儿染色体畸变的结构和频率。材料和方法。对2015 - 2017年在阿拉木图“儿科和儿科外科科学中心”肿瘤血液科就诊的儿童进行了病史回顾性分析。研究了310例原发性急性白血病患者的病史。结果和讨论。在310例患者中,158例(51%)患者在骨髓母细胞细胞遗传学和分子细胞遗传学(原位杂交)研究中分离到不同的染色体畸变。正常核型102例(33%)。结论。75.5%的急性白血病检测到淋巴细胞变异,表明其在不同年龄儿童AL结构中起主导作用。在所有OL病例中,有22.6%被确定为AML。ALL患者中最常见的染色体重排是胚细胞染色体高二倍体(10.6%)和t(12;21)(p13;q22)/ETV6-RUNX1, 37例(16%)患者检测到。最常见的AML畸变是t (8;21) (q22;q22)/RUNX1-RUNX1T1,在15例(21.4%)患者中发现。关键词:急性白血病,骨髓,母细胞,核型,染色体畸变,细胞遗传学研究。
{"title":"Comparative analysis of chromosomal aberrations in children with acute leukemia","authors":"Zhansaya Nessipbayeva, M. Bulegenova, M. Karazhanova, Dina Nurpisova","doi":"10.31082/1728-452x-2020-215-216-5-6-7-14","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-215-216-5-6-7-14","url":null,"abstract":"Leukemia is a hematopoetic tissue tumor with a primary lesion of the bone marrow, where the morphological substrate is the blast cell. Chromosomal and molecular genetic aberrations play a major role in the acute leukemia pathogenesis, determing the morphological, immunological and clinical features of the disease. Our study was aimed to to analyze retrospectively the structure and frequency of chromosomal aberrations in children with initially diagnosed acute leukemia. Material and methods. Medical histories retrospective analysis of children charged to oncohematology department of the «Scientific Center of Pediatrics and Pediatric Surgery» in Almaty for the period 2015 - 2017 was carried out. 310 histories with primary diagnosed acute leukemia were studied. Results and discussion. Among 310 patients different chromosome aberrations were isolated in 158 patients (51%) during cytogenetic and molecular cytogenetic (in situ hybridization) studies of bone marrow blast cells. A normal karyotype was observed in 102 patients (33%). Conclusion. The lymphoblastic variant of acute leukemia was determined in 75.5%, that indicates its leading role in AL structure among the children of different ages. AML was determined in 22.6% of all OL cases. The most frequent chromosomal rearrangement in ALL patients was blast cell chromosome hyperdiploidy (10,6%) and t(12;21)(p13;q22)/ETV6-RUNX1,which was detected in 37 (16%) patients. The most frequent AML abberation was t (8;21) (q22;q22)/RUNX1-RUNX1T1, identified in 15 (21.4%) patients. Keywords: acute leukemia, bone marrow, blast cells, karyotype, chromosomal aberrations, cytogenetic study.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"102 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79045804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical effectiveness of the preparation Enisamium iodide in the complex treatment of ARVI 碘化依尼沙铵制剂复合治疗ARVI的临床疗效观察
Pub Date : 2020-12-13 DOI: 10.31082/1728-452x-2020-215-216-5-6-32-37
S. Kulzhanova, G. Nurakhmetova, M. Konkayeva, Z. Smagulova
The list of etiotropic drugs recommended for the treatment of influenza and other acute respiratory viral infections is not very large and requires sufficient justification for rational tactics of their use. In accordance with the WHO strategy for combating influenza and SARS, it is necessary to continue research to study the clinical efficacy of antiviral drugs with a combined effect - etiotropic, pathogenetic and symptomatic. Enisamium iodide is one of such drugs for etiotropic and pathogenetic therapy of ARVI. Aim. To evaluate the clinical efficacy of the drug enisamium iodide (amizone) in the complex therapy of acute respiratory viral infections (ARVI). Material and methods. The randomized study included 40 patients who were treated during the epidemic season of influenza and ARVI 2019. Patients of the main group received enisamium iodide along with symptomatic therapy, the control group received only symptomatic therapy. The clinical efficacy of treatment was assessed by the duration of the main clinical symptoms of ARVI, the proportion of patients who developed complications requiring antibiotics. Statistical processing of the obtained data was carried out using the SPSS 12.0.2 software for Windows. Results and discussion. The results of a randomized study showed the clinical efficacy and safety of amizone (enisamium iodide) in the complex treatment of acute respiratory viral infections of various etiologies, compared with the use of only symptomatic therapy drugs. The duration of fever and the main clinical symptoms of acute respiratory viral infections were statistically significantly less in the study group than in the control group. Accordingly, the proportion of patients whose body temperature returned to normal on days 2–3 of treatment was statistically significantly higher in the group of patients taking enisamium iodide. Complications requiring antibiotic prescription have been reported only in control patients. Also, the drug was well tolerated and there were no side effects during its use. Conclusions. The results obtained confirmed that enisamium a iodide (amizon) has a good clinical effect in ARVI, reduces the likelihood of complications in patients. The high sensitivity of various respiratory viruses to the drug allows it to be used without etiological decoding of ARVI. Keywords: acute respiratory viral infections (ARVI), influenza, enisamium iodide (amizone), antiviral therapy, clinical efficacy, safety.
推荐用于治疗流感和其他急性呼吸道病毒感染的致病因药物清单不是很大,需要对其合理使用策略进行充分的论证。根据世界卫生组织抗击流感和非典型肺炎的战略,有必要继续研究具有致病、致病和症状综合作用的抗病毒药物的临床疗效。碘化异硝铵是ARVI的致病性药物之一。的目标。评价碘化依米沙铵(阿米松)复合治疗急性呼吸道病毒感染(ARVI)的临床疗效。材料和方法。这项随机研究包括40名在2019年流感和ARVI流行季节接受治疗的患者。主组患者在对症治疗的同时给予碘化乙铵治疗,对照组患者仅对症治疗。通过ARVI主要临床症状的持续时间、出现需要抗生素治疗的并发症的患者比例来评估治疗的临床疗效。采用SPSS 12.0.2软件对所得数据进行统计处理。结果和讨论。一项随机研究的结果显示,与仅使用对症治疗药物相比,阿米松(碘化依尼沙铵)在复杂治疗各种病因的急性呼吸道病毒感染中的临床疗效和安全性。研究组患者发热时间、急性呼吸道病毒感染主要临床症状均明显少于对照组,差异有统计学意义。因此,服用碘化铵组患者在治疗第2 ~ 3天体温恢复正常的比例有统计学意义。需要抗生素处方的并发症仅在对照患者中有报道。此外,该药耐受性良好,在使用过程中没有副作用。结论。结果证实,碘化咪沙铵(amizon)治疗ARVI具有良好的临床效果,降低了患者并发症的发生可能性。各种呼吸道病毒对该药的高敏感性使其无需对ARVI进行病因学解码即可使用。关键词:急性呼吸道病毒感染(ARVI),流感,碘化乙胺(阿米松),抗病毒治疗,临床疗效,安全性
{"title":"Clinical effectiveness of the preparation Enisamium iodide in the complex treatment of ARVI","authors":"S. Kulzhanova, G. Nurakhmetova, M. Konkayeva, Z. Smagulova","doi":"10.31082/1728-452x-2020-215-216-5-6-32-37","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-215-216-5-6-32-37","url":null,"abstract":"The list of etiotropic drugs recommended for the treatment of influenza and other acute respiratory viral infections is not very large and requires sufficient justification for rational tactics of their use. In accordance with the WHO strategy for combating influenza and SARS, it is necessary to continue research to study the clinical efficacy of antiviral drugs with a combined effect - etiotropic, pathogenetic and symptomatic. Enisamium iodide is one of such drugs for etiotropic and pathogenetic therapy of ARVI. Aim. To evaluate the clinical efficacy of the drug enisamium iodide (amizone) in the complex therapy of acute respiratory viral infections (ARVI). Material and methods. The randomized study included 40 patients who were treated during the epidemic season of influenza and ARVI 2019. Patients of the main group received enisamium iodide along with symptomatic therapy, the control group received only symptomatic therapy. The clinical efficacy of treatment was assessed by the duration of the main clinical symptoms of ARVI, the proportion of patients who developed complications requiring antibiotics. Statistical processing of the obtained data was carried out using the SPSS 12.0.2 software for Windows. Results and discussion. The results of a randomized study showed the clinical efficacy and safety of amizone (enisamium iodide) in the complex treatment of acute respiratory viral infections of various etiologies, compared with the use of only symptomatic therapy drugs. The duration of fever and the main clinical symptoms of acute respiratory viral infections were statistically significantly less in the study group than in the control group. Accordingly, the proportion of patients whose body temperature returned to normal on days 2–3 of treatment was statistically significantly higher in the group of patients taking enisamium iodide. Complications requiring antibiotic prescription have been reported only in control patients. Also, the drug was well tolerated and there were no side effects during its use. Conclusions. The results obtained confirmed that enisamium a iodide (amizon) has a good clinical effect in ARVI, reduces the likelihood of complications in patients. The high sensitivity of various respiratory viruses to the drug allows it to be used without etiological decoding of ARVI. Keywords: acute respiratory viral infections (ARVI), influenza, enisamium iodide (amizone), antiviral therapy, clinical efficacy, safety.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75711285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical development of teenagers remaining without parental care 没有父母照顾的青少年的身体发育
Pub Date : 2020-12-13 DOI: 10.31082/1728-452x-2020-215-216-5-6-2-6
Lyazat Orakbai, N. Dzhaynakbaev, Togzhan Salmenova, Alexandr Vdovcev, Azhar Adilkhanova, Zh M Meirmanova
Preserving and strengthening the health of orphaned children and children left without parental care is of great medical, social and public significance. The aim of the study. Assess the health status of adolescents without parental care. Material and methods. The object of the study was teenagers left without parental care (adolescents from 10 to 18 years old). The total sample size was 2,499 adolescents. Assessment of physical development was carried out on the hardware-software complex "Health-Express". This high-tech equipment, developed by the "Kazakh-Russian Medical University". Results and discussion. The authors have shown that at the present stage, there are negative trends in the number of children with disharmonious physical development due to lack of body length. For example, the frequency of identified disharmonious physical development in the age group 10-14 years was 71.8% and in the first childhood group 28.2%. The main reason for disharmonious physical development was a growth deficiency and moderate body weight deficiency. Conclusions. The main reason for the disharmonious physical development of adolescents left without parental care was a deficit in height and a moderate deficit in body weight. Keywords: physical development, teenagers, orphans, "Health-Express", body mass index, body length.
保护和加强孤儿和无父母照料儿童的健康具有重大的医疗、社会和公共意义。研究的目的。评估没有父母照料的青少年的健康状况。材料和方法。本研究的对象是没有父母照顾的青少年(10至18岁的青少年)。总样本量为2499名青少年。在“Health-Express”硬件软件综合体上进行身体发育评估。这种高科技设备由“哈萨克-俄罗斯医科大学”研制。结果和讨论。作者认为,现阶段,由于体长不足而导致身体发育不协调的儿童数量呈下降趋势。例如,10-14岁年龄组确定的身体发育不协调的频率为71.8%,第一个儿童组为28.2%。发育不协调的主要原因是发育不足和体重不足。结论。没有父母照顾的青少年身体发育不协调的主要原因是身高不足和体重适度不足。关键词:身体发育,青少年,孤儿,健康快递,体重指数,体长
{"title":"Physical development of teenagers remaining without parental care","authors":"Lyazat Orakbai, N. Dzhaynakbaev, Togzhan Salmenova, Alexandr Vdovcev, Azhar Adilkhanova, Zh M Meirmanova","doi":"10.31082/1728-452x-2020-215-216-5-6-2-6","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-215-216-5-6-2-6","url":null,"abstract":"Preserving and strengthening the health of orphaned children and children left without parental care is of great medical, social and public significance. The aim of the study. Assess the health status of adolescents without parental care. Material and methods. The object of the study was teenagers left without parental care (adolescents from 10 to 18 years old). The total sample size was 2,499 adolescents. Assessment of physical development was carried out on the hardware-software complex \"Health-Express\". This high-tech equipment, developed by the \"Kazakh-Russian Medical University\". Results and discussion. The authors have shown that at the present stage, there are negative trends in the number of children with disharmonious physical development due to lack of body length. For example, the frequency of identified disharmonious physical development in the age group 10-14 years was 71.8% and in the first childhood group 28.2%. The main reason for disharmonious physical development was a growth deficiency and moderate body weight deficiency. Conclusions. The main reason for the disharmonious physical development of adolescents left without parental care was a deficit in height and a moderate deficit in body weight. Keywords: physical development, teenagers, orphans, \"Health-Express\", body mass index, body length.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72944150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis of pulmonary hypertension associated whith systemic sclerosis 肺动脉高压合并系统性硬化症的诊断
Pub Date : 2020-12-13 DOI: 10.31082/1728-452x-2020-215-216-5-6-15-23
Nazym Junusbayeva, B. Issayeva
Systemic sclerosis is the most common autoimmune disease associated with pulmonary hypertension. Pulmonary hypertension is a potential predictor of early death, and therefore, recently, interest in a comprehensive study of the diagnosis of pulmonary hypertension associated with systemic sclerosis has been increasing among researchers. Aim. Consideration of current diagnostic issues, as well as the principles of using diagnostic algorithms to verify pulmonary hypertension associated with systemic sclerosis, applied in daily clinical practice. Material and methods. In order to study the literature data, a search was carried out for information on this problem up to 10 years in depth in the Web of Science, PubMed/MEDLINE. During the search, the following terms were used individually and in combination: "systemic sclerosis", "pulmonary hypertension", "DETECT algorithm", "catheterization of the right heart chambers". The main search criteria were studies based on the study of patients with pulmonary hypertension associated with systemic sclerosis: meta-analyzes, original studies, retrospective and cohort studies. Results and discussion. The clinical symptoms of pulmonary hypertension can be nonspecific, which greatly complicates the diagnosis of the disease in the early stages. The absence of a specific clinical picture before the development of an advanced stage of pulmonary hypertension leads to late verification of the diagnosis. Key algorithms used in the daily practice of a doctor make it possible to minimize the number of undiagnosed cases of pulmonary hypertension. Conclusions. Diagnosis of PH associated with systemic sclerosis is often challenging for clinicians to practice. Early diagnosis and therefore treatment of PH are of paramount importance as they improve survival rates in patients with systemic sclerosis. Keywords: systemic sclerosis, pulmonary hypertension, screening, DETECT algorithm, right heart catheterization.
系统性硬化症是与肺动脉高压相关的最常见的自身免疫性疾病。肺动脉高压是早期死亡的潜在预测因素,因此,最近,研究人员对肺动脉高压与系统性硬化症相关诊断的综合研究越来越感兴趣。的目标。考虑当前诊断问题,以及在日常临床实践中使用诊断算法验证系统性硬化症相关肺动脉高压的原则。材料和方法。为了研究文献数据,在Web of Science, PubMed/MEDLINE上进行了长达10年的关于这个问题的深入搜索。在搜索过程中,以下术语被单独或组合使用:“系统性硬化症”、“肺动脉高压”、“DETECT算法”、“右心室导管插入”。主要检索标准是基于肺动脉高压合并系统性硬化症患者研究的研究:meta分析、原始研究、回顾性研究和队列研究。结果和讨论。肺动脉高压的临床症状可能是非特异性的,这大大增加了早期诊断的复杂性。在肺动脉高压发展到晚期之前缺乏具体的临床表现导致诊断的验证较晚。在医生的日常实践中使用的关键算法可以最大限度地减少未确诊的肺动脉高压病例的数量。结论。诊断PH与系统性硬化症往往是具有挑战性的临床医生的做法。早期诊断和治疗PH是至关重要的,因为它们提高了系统性硬化症患者的生存率。关键词:系统性硬化症,肺动脉高压,筛查,DETECT算法,右心导管。
{"title":"Diagnosis of pulmonary hypertension associated whith systemic sclerosis","authors":"Nazym Junusbayeva, B. Issayeva","doi":"10.31082/1728-452x-2020-215-216-5-6-15-23","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-215-216-5-6-15-23","url":null,"abstract":"Systemic sclerosis is the most common autoimmune disease associated with pulmonary hypertension. Pulmonary hypertension is a potential predictor of early death, and therefore, recently, interest in a comprehensive study of the diagnosis of pulmonary hypertension associated with systemic sclerosis has been increasing among researchers. Aim. Consideration of current diagnostic issues, as well as the principles of using diagnostic algorithms to verify pulmonary hypertension associated with systemic sclerosis, applied in daily clinical practice. Material and methods. In order to study the literature data, a search was carried out for information on this problem up to 10 years in depth in the Web of Science, PubMed/MEDLINE. During the search, the following terms were used individually and in combination: \"systemic sclerosis\", \"pulmonary hypertension\", \"DETECT algorithm\", \"catheterization of the right heart chambers\". The main search criteria were studies based on the study of patients with pulmonary hypertension associated with systemic sclerosis: meta-analyzes, original studies, retrospective and cohort studies. Results and discussion. The clinical symptoms of pulmonary hypertension can be nonspecific, which greatly complicates the diagnosis of the disease in the early stages. The absence of a specific clinical picture before the development of an advanced stage of pulmonary hypertension leads to late verification of the diagnosis. Key algorithms used in the daily practice of a doctor make it possible to minimize the number of undiagnosed cases of pulmonary hypertension. Conclusions. Diagnosis of PH associated with systemic sclerosis is often challenging for clinicians to practice. Early diagnosis and therefore treatment of PH are of paramount importance as they improve survival rates in patients with systemic sclerosis. Keywords: systemic sclerosis, pulmonary hypertension, screening, DETECT algorithm, right heart catheterization.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82189877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of golimumab in the treatment of ankylosing spondylitis and rheumatoid arthritis (own experience) golimumab治疗强直性脊柱炎、类风湿性关节炎的疗效(亲身体会)
Pub Date : 2020-12-13 DOI: 10.31082/1728-452x-2020-215-216-5-6-24-31
Madina Murzabayeva
Genetic engineering drugs are used to treat rheumatic diseases. Based on the results of multicenter studies, the effectiveness and safety of golimumab, a representative of the group of tumor necrosis factor inhibitors in various categories of patients, was proved.. Purpose of research.To evaluate the effectiveness of golimumab in the treatment of ankylosing spondylitis and rheumatoid arthritis. Material and methods. The efficacy of golimumab was analyzed based on clinical and laboratory data in 7 patients with ankylosing spondylitis and 6 patients with rheumatoid arthritis. These studies are described against the background of a one-year follow-up of patients. Results and discussion. The observation group consisted of 7 patients with ankylosing spondylarthritis (as) and 6 patients with a diagnosis of rheumatoid arthritis. In all patients with (as) at the beginning of the study, the BASDAI index >6 points, and in 5 patients, the ASDASRB index was 3.5±0.45. In 4 patients with the diagnosis (as), the BASFI index was 7±0.67, and in three patients-5±0.3. the BASMI Index in all studied patients revealed pronounced disorders and was 7.5±0.85. Positive dynamics was observed during golimumab therapy. A patient with a high degree of BASDAI activity >6 showed improvement on the 4th injection of golimumab, the Average score of BASDAI and BASFI indices on golimumab was lower by the 20th week, compared with the start of therapy. By the 24th week of therapy, the BASDAI index was down 31%. The follow-up group with the diagnosis of rheumatoid arthritis consisted of 6 patients, including 1 male and 5 female, with an average age of 38±0.5 years. In a male patient, the DAS-28 index was 5.2±0.06, the SDAI index was 27±0.05, and the CDAI index was 23±0.03. In women, the DAS-28 index was 3.8±0.03, and the SDAI index was 19±0.3 in 5 patients, and the CDAI index was 20±0.3. after adding golimumab, the General condition of all patients improved clinically after the second injection, and all indicators of inflammatory activity decreased. Golimumab is a human monoclonal antibody to tumor necrosis factor (TNF)α. The effect of golimumab is due to the binding and neutralization of soluble and membrane-bound forms of TNF)α. TNF)α. it is a cytokine detected in patients with rheumatoid arthritis, ankylosing spondylarthritis. Conclusion. Against the background of the use of golimumab, the clinical effect was noted in the form of complete relief of joint pain and positive dynamics according to the studied laboratory parameters. Keywords: rheumatoid arthritis, ankylosing spondylitis, golimumab, efficacy.
基因工程药物被用于治疗风湿性疾病。基于多中心研究结果,证明了作为肿瘤坏死因子抑制剂组代表的golimumab在各类患者中的有效性和安全性。研究目的。评价格利姆单抗治疗强直性脊柱炎和类风湿关节炎的疗效。材料和方法。根据7例强直性脊柱炎患者和6例类风湿关节炎患者的临床和实验室数据,分析golimumab的疗效。这些研究是在对患者进行一年随访的背景下进行的。结果和讨论。观察组包括7例强直性脊柱炎(as)和6例诊断为类风湿关节炎的患者。研究开始时,所有(as)患者的BASDAI指数均>6分,其中5例患者的ASDASRB指数为3.5±0.45。4例确诊(as)患者BASFI指数为7±0.67,3例为-5±0.3。所有患者的BASMI指数均为7.5±0.85。在戈利姆单抗治疗期间观察到积极的动态。高BASDAI活性度>6的患者在第4次注射戈利姆单抗时出现改善,到第20周,与治疗开始时相比,戈利姆单抗的BASDAI和BASFI指数的平均评分有所降低。治疗第24周,BASDAI指数下降31%。诊断为类风湿关节炎的随访组6例,男1例,女5例,平均年龄38±0.5岁。男性患者DAS-28指数为5.2±0.06,SDAI指数为27±0.05,CDAI指数为23±0.03。5例女性DAS-28指数为3.8±0.03,SDAI指数为19±0.3,CDAI指数为20±0.3。加用golimumab后,所有患者第二次注射后临床一般情况改善,炎症活性各项指标均下降。Golimumab是一种抗肿瘤坏死因子(TNF)α的人单克隆抗体。golimumab的作用是由于结合和中和可溶性和膜结合形式的TNF)α。肿瘤坏死因子α。它是一种在类风湿关节炎、强直性脊柱炎患者中检测到的细胞因子。结论。在使用golimumab的背景下,根据研究的实验室参数,临床效果以完全缓解关节疼痛和积极动态的形式被注意到。关键词:类风湿关节炎,强直性脊柱炎,戈利单抗,疗效。
{"title":"Efficacy of golimumab in the treatment of ankylosing spondylitis and rheumatoid arthritis (own experience)","authors":"Madina Murzabayeva","doi":"10.31082/1728-452x-2020-215-216-5-6-24-31","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-215-216-5-6-24-31","url":null,"abstract":"Genetic engineering drugs are used to treat rheumatic diseases. Based on the results of multicenter studies, the effectiveness and safety of golimumab, a representative of the group of tumor necrosis factor inhibitors in various categories of patients, was proved.. Purpose of research.To evaluate the effectiveness of golimumab in the treatment of ankylosing spondylitis and rheumatoid arthritis. Material and methods. The efficacy of golimumab was analyzed based on clinical and laboratory data in 7 patients with ankylosing spondylitis and 6 patients with rheumatoid arthritis. These studies are described against the background of a one-year follow-up of patients. Results and discussion. The observation group consisted of 7 patients with ankylosing spondylarthritis (as) and 6 patients with a diagnosis of rheumatoid arthritis. In all patients with (as) at the beginning of the study, the BASDAI index >6 points, and in 5 patients, the ASDASRB index was 3.5±0.45. In 4 patients with the diagnosis (as), the BASFI index was 7±0.67, and in three patients-5±0.3. the BASMI Index in all studied patients revealed pronounced disorders and was 7.5±0.85. Positive dynamics was observed during golimumab therapy. A patient with a high degree of BASDAI activity >6 showed improvement on the 4th injection of golimumab, the Average score of BASDAI and BASFI indices on golimumab was lower by the 20th week, compared with the start of therapy. By the 24th week of therapy, the BASDAI index was down 31%. The follow-up group with the diagnosis of rheumatoid arthritis consisted of 6 patients, including 1 male and 5 female, with an average age of 38±0.5 years. In a male patient, the DAS-28 index was 5.2±0.06, the SDAI index was 27±0.05, and the CDAI index was 23±0.03. In women, the DAS-28 index was 3.8±0.03, and the SDAI index was 19±0.3 in 5 patients, and the CDAI index was 20±0.3. after adding golimumab, the General condition of all patients improved clinically after the second injection, and all indicators of inflammatory activity decreased. Golimumab is a human monoclonal antibody to tumor necrosis factor (TNF)α. The effect of golimumab is due to the binding and neutralization of soluble and membrane-bound forms of TNF)α. TNF)α. it is a cytokine detected in patients with rheumatoid arthritis, ankylosing spondylarthritis. Conclusion. Against the background of the use of golimumab, the clinical effect was noted in the form of complete relief of joint pain and positive dynamics according to the studied laboratory parameters. Keywords: rheumatoid arthritis, ankylosing spondylitis, golimumab, efficacy.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90964781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical aspects of congenital adrenal hyperplasia due to 21-hydroxylase deficiency 21-羟化酶缺乏所致先天性肾上腺增生的临床分析
Pub Date : 2020-08-31 DOI: 10.31082/1728-452x-2020-213-214-3-4-26-32
R. Bazarbekova, T. Ermakhanova, Oral Onlassynova, Ayaulym Alpan, A. Satybaldina, Ardak Orazbay, Malika Akhmerova, Aikerim Slamova, Zaure Mussakhanova
21-hydroxylase deficiency is the cause of one of the most common hereditary diseases - congenital adrenal hyperplasia (CAH). The level of residual activity of 21-hydroxylase determines the clinical form and severity of the course of the disease. The article presents the clinical characteristics of two forms of CAH – salt-wasting and simple virilizing. Objective. To study the clinical aspects of CAH due to 21-hydroxylase deficiency in children. Material and methods. We analyzed 57 archived case histories and 58 extracts from case histories of children from 0 to 18 years old with an established diagnosis of CAH. In general, the sample comprised cases, of which 36 were boys (48%) and 39 (52%) girls. Results and discussion. Of the 75 children with CAH, 43 (57.3%) had a salt-wasting form, 32 (42.7%) had a simple virilizing form. In children with salt-wasting form, the leading clinical manifestation was salt loss syndrome, with simple virilizing - viril syndrome. The average age of diagnosis with salt-wasting form was 1.5 months (from 1 to 2.6 months), with simple virilizing - 3 years (from 1.4 to 4.4 years). Conclusions. According to our data, in Kazakhstan, the salt- wasting form of СAH is diagnosed more often than a simple virilizing form (57.3% / 42.7%). The problems of timely diagnosis of CAH and in the selection of the appropriate passport gender of the child were identified. Keywords: congenital adrenal hyperplasia, 21-hydroxylase deficiency, salt-wasting form, simple virilizing form.
21-羟化酶缺乏是一种最常见的遗传性疾病——先天性肾上腺增生症(CAH)的病因。21-羟化酶的残余活性水平决定了疾病的临床形式和病程的严重程度。本文介绍了两种形式的CAH的临床特点-盐浪费和单纯的男性化。目标。目的:探讨21-羟化酶缺乏症患儿CAH的临床特点。材料和方法。我们分析了57例存档病例和58例从0至18岁确诊为CAH的儿童病历摘录。总的来说,样本包含病例,其中36例为男孩(48%),39例为女孩(52%)。结果和讨论。在75例CAH患儿中,43例(57.3%)为盐消耗型,32例(42.7%)为单纯男性化型。失盐型患儿临床表现以失盐综合征为主,伴单纯的阳刚-阳刚综合征。诊断为盐流失形式的平均年龄为1.5个月(从1到2.6个月),单纯的男性化- 3年(从1.4到4.4岁)。结论。根据我们的数据,在哈萨克斯坦,消耗盐型СAH比简单的男性化型更常被诊断出来(57.3% / 42.7%)。发现了CAH的及时诊断和儿童护照性别选择的问题。关键词:先天性肾上腺增生,21-羟化酶缺乏,盐耗型,单纯阳刚型。
{"title":"Clinical aspects of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","authors":"R. Bazarbekova, T. Ermakhanova, Oral Onlassynova, Ayaulym Alpan, A. Satybaldina, Ardak Orazbay, Malika Akhmerova, Aikerim Slamova, Zaure Mussakhanova","doi":"10.31082/1728-452x-2020-213-214-3-4-26-32","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-213-214-3-4-26-32","url":null,"abstract":"21-hydroxylase deficiency is the cause of one of the most common hereditary diseases - congenital adrenal hyperplasia (CAH). The level of residual activity of 21-hydroxylase determines the clinical form and severity of the course of the disease. The article presents the clinical characteristics of two forms of CAH – salt-wasting and simple virilizing. Objective. To study the clinical aspects of CAH due to 21-hydroxylase deficiency in children. Material and methods. We analyzed 57 archived case histories and 58 extracts from case histories of children from 0 to 18 years old with an established diagnosis of CAH. In general, the sample comprised cases, of which 36 were boys (48%) and 39 (52%) girls. Results and discussion. Of the 75 children with CAH, 43 (57.3%) had a salt-wasting form, 32 (42.7%) had a simple virilizing form. In children with salt-wasting form, the leading clinical manifestation was salt loss syndrome, with simple virilizing - viril syndrome. The average age of diagnosis with salt-wasting form was 1.5 months (from 1 to 2.6 months), with simple virilizing - 3 years (from 1.4 to 4.4 years). Conclusions. According to our data, in Kazakhstan, the salt- wasting form of СAH is diagnosed more often than a simple virilizing form (57.3% / 42.7%). The problems of timely diagnosis of CAH and in the selection of the appropriate passport gender of the child were identified. Keywords: congenital adrenal hyperplasia, 21-hydroxylase deficiency, salt-wasting form, simple virilizing form.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78199923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and treatment tactics features for combined echinococcosis of the chest and abdominal cavity 胸腹腔合并棘球蚴病的诊治策略特点
Pub Date : 2020-08-31 DOI: 10.31082/1728-452x-2020-213-214-3-4-17-25
B. Akimniyazova, G. Kausova, T. Yeshmuratov, Gulstan Yesetova
Combined echinococcosis of the chest and abdominal cavity is one of the cause of morbidity and disability in the Republic of Kazakhstan (RK). Currently, a threatening situation has arisen in the countries of Central Asia due to the epidemiology of dangerous zoonosis - echinococcosis. There is a tendency for an increasing in the invasion of people by this helminth in Kazakhstan. In 2017, according to statistics, 217 cases of echinococcosis per 100,000 people was detected. Echinococcosis is one of the serious reasons for the increase in the number of surgeries. The purpose of this article is to analyze the clinical cases of combined echinococcosis of the chest and abdominal cavity received at the Department of Thoracic Surgery of the National Scientific Center for Surgery named after A.N. Syzganova since 1997 to 2009. Material and methods. We conducted a study of the surgical activity of the department, the distribution of patients with combined echinococcosis by factors of social status, contact with animals and place of residence, the nature of the combined lesion of echinococcosis of the organs of the chest and abdominal cavity, who received surgical treatment. Results and discussion. According to a study of 413 patients, were identified 534 cysts: single cysts: right (30 (5.6%)) and left (21 (4.0%)) lungs, both lungs (9 (1.7%)), subphrenic surface of the liver (40 (7.4%)); multiple cysts: right (84 (15.7%)) and left (51 (9.5%)) lung, both lungs (96 (17.9%)), liver (132 (24.7%)), liver and abdominal cavity (53 (9.9%)), mediastinum (14 (2.6%)), diaphragm and retroperitoneal space (4 (0.7%)). Simultaneous echinococcectomy of 2-3 organs was performed in 261 (63.3%) patients, phased echinococcectomy of several organs with an interval of 2 weeks to 6 months was performed in 152 (36.7%) patients. Postoperative complications were revealed in 35 (8.5%) patients who were associated with combined lesions of various organs, initially complicated forms of lesions, and late referral to a doctor after long unsuccessful treatment at the place of residence. In 17 (4%) patients with an empty echinococcal cyst, a postoperative pneumonia was observed, which was resolved conservatively. Complications in the form of exudative pleurisy were observed in 12 (2.9%) patients; pleural cavity punctures were performed for all. In 6 (1.4%) patients there was suppuration of the laparotomic postoperative wound. Conclusion. The endemicity of the zone, the high contagiousness of the par-asite, the wide age range of patients, the combined defeat with parasite of many organs and different cavities - all this indicates the relevance of this topic and require further discussion and improvement of diagnostic and therapeutic tactics. The necessary for a multidisciplinary approach, namely the inclusion of oncologists and TB specialists together with surgeons in the diagnostic algorithm, is fundamental to improving diagnostic results. The tactics of treatment of combined echinococcal le
胸腹腔合并棘球蚴病是哈萨克斯坦共和国发病和致残的原因之一。目前,由于危险的人畜共患病-棘球蚴病的流行病学,中亚国家出现了一种具有威胁性的情况。在哈萨克斯坦,这种寄生虫对人类的入侵有增加的趋势。据统计,2017年每10万人检出棘球蚴病217例。棘球蚴病是手术数量增加的严重原因之一。本文旨在分析1997年至2009年在以A.N. Syzganova命名的国家外科科学中心胸外科收治的胸腹腔合并棘球蚴病的临床病例。材料和方法。我们对科室的手术活动度、社会地位、与动物接触、居住地等因素对合并棘球蚴病患者的分布、接受手术治疗的胸腹腔脏器合并棘球蚴病的性质进行了研究。结果和讨论。根据对413例患者的研究,共发现534个囊肿:单个囊肿:右肺(30个(5.6%))、左肺(21个(4.0%))、双肺(9个(1.7%))、肝膈下表面(40个(7.4%));多发囊肿:右肺84例(15.7%)、左肺51例(9.5%)、双肺96例(17.9%)、肝132例(24.7%)、肝腹腔53例(9.9%)、纵隔14例(2.6%)、膈膜及腹膜后间隙4例(0.7%)。261例(63.3%)患者同时行2-3个器官的棘球蚴切除术,152例(36.7%)患者行数个器官的分期棘球蚴切除术。35例(8.5%)患者出现术后并发症,这些患者伴有多脏器合并病变,最初病变形式复杂,在居住地长期治疗不成功后才转诊。在17例(4%)空包虫菌囊肿患者中,观察到术后肺炎,经保守治疗。并发症为渗出性胸膜炎12例(2.9%);所有患者均行胸膜穿刺。6例(1.4%)患者出现剖腹术后伤口化脓。结论。该地区的地方性,寄生虫的高传染性,患者的年龄范围广,多器官和不同腔体的寄生虫联合失败-所有这些都表明了该主题的相关性,需要进一步讨论和改进诊断和治疗策略。多学科方法的必要性,即将肿瘤学家和结核病专家与外科医生一起纳入诊断算法,是改善诊断结果的基础。与孤立的棘球蚴病相比,联合棘球蚴病的治疗策略是根据并发症的位置、大小和存在来确定顺序和阶段。关键词。胸外科,合并包虫病,分析。
{"title":"Diagnosis and treatment tactics features for combined echinococcosis of the chest and abdominal cavity","authors":"B. Akimniyazova, G. Kausova, T. Yeshmuratov, Gulstan Yesetova","doi":"10.31082/1728-452x-2020-213-214-3-4-17-25","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-213-214-3-4-17-25","url":null,"abstract":"Combined echinococcosis of the chest and abdominal cavity is one of the cause of morbidity and disability in the Republic of Kazakhstan (RK). Currently, a threatening situation has arisen in the countries of Central Asia due to the epidemiology of dangerous zoonosis - echinococcosis. There is a tendency for an increasing in the invasion of people by this helminth in Kazakhstan. In 2017, according to statistics, 217 cases of echinococcosis per 100,000 people was detected. Echinococcosis is one of the serious reasons for the increase in the number of surgeries. The purpose of this article is to analyze the clinical cases of combined echinococcosis of the chest and abdominal cavity received at the Department of Thoracic Surgery of the National Scientific Center for Surgery named after A.N. Syzganova since 1997 to 2009. Material and methods. We conducted a study of the surgical activity of the department, the distribution of patients with combined echinococcosis by factors of social status, contact with animals and place of residence, the nature of the combined lesion of echinococcosis of the organs of the chest and abdominal cavity, who received surgical treatment. Results and discussion. According to a study of 413 patients, were identified 534 cysts: single cysts: right (30 (5.6%)) and left (21 (4.0%)) lungs, both lungs (9 (1.7%)), subphrenic surface of the liver (40 (7.4%)); multiple cysts: right (84 (15.7%)) and left (51 (9.5%)) lung, both lungs (96 (17.9%)), liver (132 (24.7%)), liver and abdominal cavity (53 (9.9%)), mediastinum (14 (2.6%)), diaphragm and retroperitoneal space (4 (0.7%)). Simultaneous echinococcectomy of 2-3 organs was performed in 261 (63.3%) patients, phased echinococcectomy of several organs with an interval of 2 weeks to 6 months was performed in 152 (36.7%) patients. Postoperative complications were revealed in 35 (8.5%) patients who were associated with combined lesions of various organs, initially complicated forms of lesions, and late referral to a doctor after long unsuccessful treatment at the place of residence. In 17 (4%) patients with an empty echinococcal cyst, a postoperative pneumonia was observed, which was resolved conservatively. Complications in the form of exudative pleurisy were observed in 12 (2.9%) patients; pleural cavity punctures were performed for all. In 6 (1.4%) patients there was suppuration of the laparotomic postoperative wound. Conclusion. The endemicity of the zone, the high contagiousness of the par-asite, the wide age range of patients, the combined defeat with parasite of many organs and different cavities - all this indicates the relevance of this topic and require further discussion and improvement of diagnostic and therapeutic tactics. The necessary for a multidisciplinary approach, namely the inclusion of oncologists and TB specialists together with surgeons in the diagnostic algorithm, is fundamental to improving diagnostic results. The tactics of treatment of combined echinococcal le","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78130645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome. Prevention of venous thromboembolism in patients with COVID-19 微血管COVID-19肺血管阻塞性血栓炎症综合征。COVID-19患者静脉血栓栓塞的预防
Pub Date : 2020-08-31 DOI: 10.31082/1728-452x-2020-213-214-3-4-2-7
A. Sugraliyev, Рlinio Cirillo
In this review, the authors describe the new concept of MicroCLOTS (microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome) - proposed by Italian multidisciplinary team headed by Ciceri F, et al. as the cause of atypical acute respiratory distress syndrome. Ciceri F, etal. hypothesise that, in predisposed individuals, alveolar viral damage is followed by an inflammatory reaction and by microvascular pulmonary thrombosis. This progressive endothelial thromboinflammatory syndrome may also involve the microvascular bed of the brain and other vital organs, leading to multiple organ failure and death. In addition, patients with COVID-19 often develop macrovascular venous thrombosis as a result of the activation of the Virchow triad. Microvascular and macrovascular thrombosis development in patients with COVID-19 is confirmed by ultrasound examination of the veins of the lower extremities and complete autopsy study. The data obtained indicate the importance of the prevention of venous thrombosis with LMWH (nadroparin, enoxaparin) and Fondaparinux sodium in all hospitalized patients with COVID-19. Keywords: COVID-19, аtypical acute respiratory distress syndrome, MicroCLOTS (microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome), thrombosis, hemostasis.
在这篇综述中,作者描述了由Ciceri F等人领导的意大利多学科团队提出的非典型急性呼吸窘迫综合征病因MicroCLOTS(微血管COVID-19肺血管阻塞性血栓炎症综合征)的新概念。Ciceri F,等。假设,在易感个体中,肺泡病毒损伤之后是炎症反应和微血管肺血栓形成。这种进行性内皮血栓炎症综合征也可累及脑和其他重要器官的微血管床,导致多器官衰竭和死亡。此外,由于Virchow三联体的激活,COVID-19患者经常发生大血管静脉血栓形成。通过下肢静脉超声检查和完整的尸检研究,确认新冠肺炎患者微血管和大血管血栓形成。本研究结果提示低分子肝素(nadroparin、依诺肝素)和氟达肝素钠预防COVID-19住院患者静脉血栓形成的重要性。关键词:COVID-19,典型急性呼吸窘迫综合征,MicroCLOTS(微血管COVID-19肺血管阻塞性血栓炎症综合征),血栓形成,止血
{"title":"Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome. Prevention of venous thromboembolism in patients with COVID-19","authors":"A. Sugraliyev, Рlinio Cirillo","doi":"10.31082/1728-452x-2020-213-214-3-4-2-7","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-213-214-3-4-2-7","url":null,"abstract":"In this review, the authors describe the new concept of MicroCLOTS (microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome) - proposed by Italian multidisciplinary team headed by Ciceri F, et al. as the cause of atypical acute respiratory distress syndrome. Ciceri F, etal. hypothesise that, in predisposed individuals, alveolar viral damage is followed by an inflammatory reaction and by microvascular pulmonary thrombosis. This progressive endothelial thromboinflammatory syndrome may also involve the microvascular bed of the brain and other vital organs, leading to multiple organ failure and death. In addition, patients with COVID-19 often develop macrovascular venous thrombosis as a result of the activation of the Virchow triad. Microvascular and macrovascular thrombosis development in patients with COVID-19 is confirmed by ultrasound examination of the veins of the lower extremities and complete autopsy study. The data obtained indicate the importance of the prevention of venous thrombosis with LMWH (nadroparin, enoxaparin) and Fondaparinux sodium in all hospitalized patients with COVID-19. Keywords: COVID-19, аtypical acute respiratory distress syndrome, MicroCLOTS (microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome), thrombosis, hemostasis.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88467915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rheumatological mimics of oncological disorders: a case report 肿瘤疾病的风湿病模拟:1例报告
Pub Date : 2020-08-31 DOI: 10.31082/1728-452x-2020-213-214-3-4-59-63
Yu Khaidarova, B. Isayeva, B. Seizhanova, Zharkynay Akhmetova, N. Batyrkhanova, A. Kulembayeva
Difficulties in diagnosing system lupus erythematosus аssociated with a diverse clinical picture where new signs of the disease appear throughout the disease, and a number of symptoms disappear. There are often cases of unusual onset of the disease with absence of skin manifestations asymptomatic course of the disease. Case summary. This article presents the history of a 37-year-old patient who had manifestations of systemic autoimmune disease with autoantibodies positivity in her debut, which led to an erroneous diagnosis and inadequate treatment. Discussion. The practice of a rheumatologist increasingly notes clinical cases requiring differential diagnosis between rheumatic diseases and paraneoplastic syndrome. "Rheumatological masks" can develop in malignant tumors of different localization at different stages of the disease, showing signs of damage to the bone-joint and ligament apparatus, muscles, vessels and internal organs. Keywords: systemic lupus erythematosus, lupus-like syndrome, paraneoplastic syndrome, differential diagnostics.
诊断系统性红斑狼疮的困难与不同的临床症状有关,在整个疾病中出现新的疾病体征,并且许多症状消失。经常有发病不寻常的病例,没有皮肤表现,病程无症状。案例总结。本文介绍了一位37岁的患者的病史,她首次出现系统性自身免疫性疾病的表现,自身抗体阳性,导致误诊和治疗不充分。讨论。风湿病学家的实践越来越多地注意到需要鉴别诊断风湿病和副肿瘤综合征的临床病例。在疾病的不同阶段,不同部位的恶性肿瘤可出现“风湿病面具”,表现出骨关节韧带、肌肉、血管和内脏器官受损的迹象。关键词:系统性红斑狼疮,狼疮样综合征,副肿瘤综合征,鉴别诊断
{"title":"Rheumatological mimics of oncological disorders: a case report","authors":"Yu Khaidarova, B. Isayeva, B. Seizhanova, Zharkynay Akhmetova, N. Batyrkhanova, A. Kulembayeva","doi":"10.31082/1728-452x-2020-213-214-3-4-59-63","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-213-214-3-4-59-63","url":null,"abstract":"Difficulties in diagnosing system lupus erythematosus аssociated with a diverse clinical picture where new signs of the disease appear throughout the disease, and a number of symptoms disappear. There are often cases of unusual onset of the disease with absence of skin manifestations asymptomatic course of the disease. Case summary. This article presents the history of a 37-year-old patient who had manifestations of systemic autoimmune disease with autoantibodies positivity in her debut, which led to an erroneous diagnosis and inadequate treatment. Discussion. The practice of a rheumatologist increasingly notes clinical cases requiring differential diagnosis between rheumatic diseases and paraneoplastic syndrome. \"Rheumatological masks\" can develop in malignant tumors of different localization at different stages of the disease, showing signs of damage to the bone-joint and ligament apparatus, muscles, vessels and internal organs. Keywords: systemic lupus erythematosus, lupus-like syndrome, paraneoplastic syndrome, differential diagnostics.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"56 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72707739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mixed anxiety-depressive adaptation disorders in the presence of the COVID-19 epidemic 新冠肺炎疫情下的混合性焦虑抑郁适应障碍
Pub Date : 2020-08-31 DOI: 10.31082/1728-452x-2020-213-214-3-4-46-52
Nikolay Negai, N. Raspopova, K. Altynbekov, Maria Dzhamantayeva, N. Logacheva
In the presence of the COVID-19 epidemic, due to quarantine measures, millions of people around the world are under the stress of infection and have to adapt to new conditions of social functioning. The high risk of developing of mixed anxiety-depressive adaptation disorders in the presence of COVID-19 quarantine measures determines the relevance of this study. Study purpose. To study the prevalence and clinical level of mixed anxiety-depressive disorders in medical personnel under the COVID-19 quarantine regime. Material and methods. 51 employees of the Republican national enterprise on the right of economic jurisdiction “Republican scientific and practical center of mental health” (RSPCMH) were examined: doctors, junior and medium-level medical personnel. The main study method is psychometric (Hospital Anxiety and Depression Score – HADS). Results and discussion. The work presents an analytical review of literature data on the problem of adaptation disorders and current international studies on mental disorders in medical workers under the COVID-19 quarantine regime. According to the results of this study, affective disorders in the form of depressive and anxiety-depressive reactions within the framework of adaptation disorders were detected in 37.3% of the medical staff of the RSPCMH. Conclusions. It was found that the higher the risk of COVID-19 infection, the more often depression is detected and in departments with a lower risk of infection, more often mixed anxiety-depressive disorders are detected. Preventive measures aimed at increasing the stress tolerance of medical workers are recommended. Key words: COVID-19, stress, adaptation disorders, anxiety, depression, stress protectors, tranquilizers.
在2019冠状病毒病疫情期间,由于采取了隔离措施,全球数百万人处于感染压力之下,不得不适应新的社会运作条件。在COVID-19隔离措施存在的情况下,发生混合性焦虑-抑郁适应障碍的高风险决定了本研究的相关性。研究的目的。目的研究新冠肺炎隔离制度下医务人员焦虑-抑郁混合障碍的患病率及临床水平。材料和方法。对51名共和民族企业经济管辖权"共和精神卫生科学与实践中心"的雇员进行了检查:医生、初级和中级医务人员。主要的研究方法是心理测量(医院焦虑与抑郁评分- HADS)。结果和讨论。本研究对COVID-19隔离制度下医务工作者适应障碍问题的文献数据和当前国际上关于精神障碍的研究进行了分析综述。根据本研究的结果,在RSPCMH的医务人员中,37.3%的人在适应障碍的框架内发现了抑郁和焦虑抑郁反应形式的情感障碍。结论。结果发现,新冠肺炎感染风险越高,抑郁症的检出率越高,感染风险较低的科室,焦虑-抑郁混合性障碍的检出率越高。建议采取预防措施,提高医务工作者的抗压能力。关键词:COVID-19,压力,适应障碍,焦虑,抑郁,压力保护剂,镇静剂
{"title":"Mixed anxiety-depressive adaptation disorders in the presence of the COVID-19 epidemic","authors":"Nikolay Negai, N. Raspopova, K. Altynbekov, Maria Dzhamantayeva, N. Logacheva","doi":"10.31082/1728-452x-2020-213-214-3-4-46-52","DOIUrl":"https://doi.org/10.31082/1728-452x-2020-213-214-3-4-46-52","url":null,"abstract":"In the presence of the COVID-19 epidemic, due to quarantine measures, millions of people around the world are under the stress of infection and have to adapt to new conditions of social functioning. The high risk of developing of mixed anxiety-depressive adaptation disorders in the presence of COVID-19 quarantine measures determines the relevance of this study. Study purpose. To study the prevalence and clinical level of mixed anxiety-depressive disorders in medical personnel under the COVID-19 quarantine regime. Material and methods. 51 employees of the Republican national enterprise on the right of economic jurisdiction “Republican scientific and practical center of mental health” (RSPCMH) were examined: doctors, junior and medium-level medical personnel. The main study method is psychometric (Hospital Anxiety and Depression Score – HADS). Results and discussion. The work presents an analytical review of literature data on the problem of adaptation disorders and current international studies on mental disorders in medical workers under the COVID-19 quarantine regime. According to the results of this study, affective disorders in the form of depressive and anxiety-depressive reactions within the framework of adaptation disorders were detected in 37.3% of the medical staff of the RSPCMH. Conclusions. It was found that the higher the risk of COVID-19 infection, the more often depression is detected and in departments with a lower risk of infection, more often mixed anxiety-depressive disorders are detected. Preventive measures aimed at increasing the stress tolerance of medical workers are recommended. Key words: COVID-19, stress, adaptation disorders, anxiety, depression, stress protectors, tranquilizers.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"73 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73405415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal "Medicine"
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1